Emerging regulatory paradigms for control of gene expression by 1,25-dihydroxyvitamin D3

Journal of Steroid Biochemistry and Molecular Biology

Volumn 121, Issue 1-2, 2010, Pages 130-135

  Pike, J Wesley ^a   Meyer, Mark B ^a   Martowicz, Melissa L ^a   Bishop, Kathleen A ^a   Lee, Seong Min ^a   Nerenz, Robert D ^a   Goetsch, Paul D ^a  

^a UNIVERSITY OF WISCONSIN MADISON   (United States)

Author keywords

BAC clone evaluation; ChIP chip analysis; ChIP seq analysis; Distal transcriptional regulation; Genome wide analysis; Histone acetylation; RNA polymerase II recruitment; VDR RXR binding

Indexed keywords

CALCITRIOL; RETINOIC ACID RECEPTOR; HISTONE; LIGAND;

ANIMAL CELL; ARTICLE; ARTIFICIAL CHROMOSOME; BACTERIAL CHROMOSOME; CELL; CHROMOSOME; DNA HYBRIDIZATION; ENHANCER REGION; GENE CONTROL; GENE EXPRESSION; GENE TARGETING; GENOME; MOUSE; NONHUMAN; RECEPTOR BINDING; TRANSCRIPTION REGULATION; 3T3 CELL LINE; ACETYLATION; ANIMAL; BACTERIAL ARTIFICIAL CHROMOSOME; CHEMISTRY; CHROMATIN IMMUNOPRECIPITATION; DNA MICROARRAY; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; HUMAN;

3T3 CELLS; ACETYLATION; ANIMALS; CALCITRIOL; CHROMATIN IMMUNOPRECIPITATION; CHROMOSOMES, ARTIFICIAL, BACTERIAL; ENHANCER ELEMENTS, GENETIC; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENOME; HISTONES; HUMANS; LIGANDS; MICE; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS;

BACTERIA (MICROORGANISMS);

EID: 77954763087     PISSN: 09600760     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jsbmb.2010.02.036     Document Type: Article

References (32)

1. DeLuca H.F. Overview of general physiologic features and functions of vitamin D. Am. J. Clin. Nutr. 2004, 80(6 Suppl.):1689S-1696S.
2. Jurutka P.W., Whitfield G.K., Hsieh J.C., Thompson P.D., Haussler C.A., Haussler M.R. Molecular nature of the vitamin D receptor and its role in regulation of gene expression. Rev. Endocr. Metab. Disord. 2001, 2(2):203-216.
3. Shiau A.K., Barstad D., Loria P.M., Cheng L., Kushner P.J., Agard D.A., Greene G.L. The structural basis of estrogen receptor/coactivator recognition and the antagonism of this interaction by tamoxifen. Cell 1998, 95(7):927-937.
4. 3 hormone analogues and a LXXLL-containing coactivator peptide. Biochemistry 2004, 43(14):4101-4110.
5. He B., Wilson E. Electrostatic modulation in steroid receptor recruitment of LXXLL and FXXLF motifs. Mol. Cell. Biol. 2003, 23(6):2135-2150.
6. 3 stimulates cyclic vitamin D receptor/retinoid X receptor DNA-binding, co-activator recruitment, and histone acetylation in intact osteoblasts. J. Bone Miner. Res. 2005, 20(2):305-317.
7. Glass C., Rosenfeld M. The coregulator exchange in transcriptional functions of nuclear receptors. Genes Dev. 2000, 14(2):121-141.
8. McKenna N., O'Malley B. Combinatorial control of gene expression by nuclear receptors and coregulators. Cell 2002, 108(4):465-474.
9. Wells J., Farnham P. Characterizing transcription factor binding sites using formaldehyde crosslinking and immunoprecipitation. Methods 2002, 26(1):48-56.
10. Shang Y., Myers M., Brown M. Formation of the androgen receptor transcription complex. Mol. Cell 2002, 9(3):601-610.
11. Métivier R., Penot G., Hübner M., Reid G., Brand H., Kos M., Gannon F. Estrogen receptor-alpha directs ordered, cyclical, and combinatorial recruitment of cofactors on a natural target promoter. Cell 2003, 115(6):751-763.
12. Wang J., Derynck M., Nonaka D., Khodabakhsh D., Haqq C., Yamamoto K. Chromatin immunoprecipitation (ChIP) scanning identifies primary glucocorticoid receptor target genes. Proc. Natl. Acad. Sci. U.S.A. 2004, 101(44):15603-15608.
13. Carroll J., Meyer C., Song J., Li W., Geistlinger T., Eeckhoute J., Brodsky A., Keeton E., Fertuck K., Hall G., Wang Q., Bekiranov S., Sementchenko V., Fox E., Silver P., Gingeras T., Liu X., Brown M. Genome-wide analysis of estrogen receptor binding sites. Nat. Genet. 2006, 38(11):1289-1297.
14. Lin C., Vega V., Thomsen J., Zhang T., Kong S., Xie M., Chiu K., Lipovich L., Barnett D., Stossi F., Yeo A., George J., Kuznetsov V., Lee Y., Charn T., Palanisamy N., Miller L., Cheung E., Katzenellenbogen B., Ruan Y., Bourque G., Wei C., Liu E. Whole-genome cartography of estrogen receptor alpha binding sites. PLoS Genet. 2007, 3(6):e87.
15. Welboren W., van Driel M., Janssen-Megens E., van Heeringen S., Sweep F., Span P., Stunnenberg H. ChIP-Seq of ERalpha and RNA polymerase II defines genes differentially responding to ligands. EMBO J. 2009, 28(10):1418-1428.
16. Lefterova M., Zhang Y., Steger D., Schupp M., Schug J., Cristancho A., Feng D., Zhuo D., Stoeckert C.J., Liu X., Lazar M. PPARgamma and C/EBP factors orchestrate adipocyte biology via adjacent binding on a genome-wide scale. Genes Dev. 2008, 22(21):2941-2952.
17. Welboren W., Stunnenberg H., Sweep F., Span P. Identifying estrogen receptor target genes. Mol. Oncol. 2007, 1(2):138-143.
18. 3 regulates the expression of low-density lipoprotein receptor-related protein 5 via deoxyribonucleic acid sequence elements located downstream of the start site of transcription. Mol. Endocrinol. 2006, 20(9):2215-2230.
19. 3 is mediated through multiple long-range enhancers. Mol. Cell. Biol. 2006, 26(17):6469-6486.
20. 3. Mol. Endocrinol. 2006, 20(6):1231-1247.
21. Kuan P., Chun H., Keleş S. CMARRT: a tool for the analysis of ChIP-chip data from tiling arrays by incorporating the correlation structure. Pac. Symp. Biocomput. 2008, 515-526.
22. Stein L., Mungall C., Shu S., Caudy M., Mangone M., Day A., Nickerson E., Stajich J., Harris T., Arva A., Lewis S. The generic genome browser: a building block for a model organism system database. Genome Res. 2002, 12(10):1599-1610.
23. Meyer M.B., Goetsch P.D., Pike J.W. Genome-wide analysis of the VDR/RXR cistrome in osteoblast cells provides new mechanistic insight into the actions of the vitamin D hormone. J. Ster. Biochem. Mol. Biol. 2010, 121:136-141.
24. 3 is mediated through multiple long-range enhancers. Mol. Cell. Biol. 2006, 26(17):6469-6486.
25. 3. Mol. Endocrinol. 2006, 20(6):1231-1247.
26. Zella L., Meyer M.B., Nerenz R.D., Lee S.M., Martowicz M.L., Pike J.W. Multifunctional enhancers regulate mouse and human vitamin D receptor gene transcription. Mol. Endocrinol. 2010, 24(1):128-147.
27. Warming S., Costantino N., Court D.L., Jenkins N.A., Copeland N.G. Simple and highly efficient BAC recombineering using galK selection. Nucleic Acids Res. 2005, 33(4):e36.
28. Fu Q., Manolagas S., O'Brien C. Parathyroid hormone controls receptor activator of NF-kappaB ligand gene expression via a distant transcriptional enhancer. Mol. Cell. Biol. 2006, 26(17):6453-6468.
29. M.B. Meyer, J. Nie, R. Stewart, J.A. Thomson, J.W. Pike, Genome-wide analysis of the VDR/RXR cistrome in osteoblasts provides new mechanistic insight into the actions of the vitamin D hormone, ASBMR 31st Annual Meeting (ABST) (2009) SA0209.
30. Malloy P., Pike J., Feldman D. The vitamin D receptor and the syndrome of hereditary 1,25-dihydroxyvitamin D-resistant rickets. Endocr. Rev. 1999, 20(2):156-188.
31. 3 and its receptor. J. Steroid Biochem. Mol. Biol. 2007, 103(3-5):389-395.
32. Galli C., Zella L.A., Fretz J.A., Fu Q., Pike J.W., Weinstein R.S., Manolagas S.C., O'Brien C.A. Targeted deletion of a distant transcriptional enhancer of the receptor activator of nuclear factor-kappaB ligand gene reduces bone remodeling and increases bone mass. Endocrinology 2008, 149(1):146-153.